Streetbeat News

DCGO

DocGo Inc.

https://www.docgo.com

Industry

Medical - Care Facilities

DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.

Open

2.93

Mkt cap

291M

Volume

1.1M

High

3.00

P/E Ratio

15.83

52-wk high

5.67

Low

2.75

Div yield

N/A

52-wk low

2.75

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on DocGo (NASDAQ:DCGO) and maintained a $13 price target.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:42 pm

DocGo (NASDAQ:DCGO) has received 9 bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the stock, according to these analysts, is $13.56, with a high of $15.00 and a low of $12.00. This average price target has increased by 13.0% over the past month.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 10:31 am

The article lists the stocks that gained and lost the most during Wednesday's mid-day trading session. Among the gainers were Palisade Bio, FOXO Technologies, iCoreConnect, Marin Software, and AeroVironment, which all saw significant increases in their share prices due to various positive developments. On the other hand, EZGO Technologies, Verb Technology Company, The Alkaline Water Company, Lion Group Holding, and Akoustis Technologies were among the biggest losers, with their share prices falling due to various negative developments.

Portfolio Pulse from Lisa Levin

September 06, 2023 | 5:16 pm

Several healthcare stocks experienced significant movement in Wednesday's pre-market session. Palisade Bio, Trevena, NeuBase Therapeutics, Journey Medical, Reshape Lifesciences, and NextGen Healthcare saw increases ranging from 14.74% to 65.3%. Meanwhile, Applied Molecular, RVL Pharmaceuticals, Axcella Health, DocGo, Cellectar Biosciences, and Addex Therapeutics experienced decreases ranging from 8.4% to 14.0%.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 1:06 pm

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

August 23, 2023 | 9:52 am

Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.

Portfolio Pulse from richadhand@benzinga.com

August 22, 2023 | 11:49 am

In the last quarter, DocGo (NASDAQ:DCGO) received six bullish analyst ratings with an average price target of $13.33, indicating potential upside from the current price of $8.92. The average price target has increased by 11.08% over the past month.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 9:00 pm

BTIG analyst David Larsen has initiated coverage on DocGo (NASDAQ:DCGO) with a Buy rating and a price target of $15.

Portfolio Pulse from richadhand@benzinga.com

August 18, 2023 | 10:08 am

The article lists the stocks that gained and lost the most in Tuesday's mid-day session. Notable gainers include Nuburu, Inc. (NYSE:BURU) which jumped 185.6% after announcing a contract with NASA, and Vivos Therapeutics, Inc. (NASDAQ:VVOS) which gained 91.1% after a 10% fall on Monday. Notable losers include Proterra Inc. (NASDAQ:PTRA) which dipped 79.6% after filing for Chapter 11 bankruptcy, and SeaChange International, Inc. (NASDAQ:SEAC) which fell 41.3% after announcing voluntary SEC deregistration and Nasdaq delisting.

Portfolio Pulse from Lisa Levin

August 08, 2023 | 5:13 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.